News

Turning over a new leaf

Ingredients obtained by KnipBio from specialised strains of leaf symbiont bacteria have been demonstrated to offer promising alternatives to fishmeal in aquafeeds, following a number of recent trials. Read more >>
Read more...

Corbus Pharmaceuticals Announces Presentation of Six Abstracts and New Anabasum Data at 2017 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology ("ACR") 2017 Annual Meeting being held November 3-8, 2017 in San Diego, California. Read more >>
Read more...

VisionCorps offers visually impaired chance to try eSight & NuEyes electronic smart glasses

On Oct. 5, VisionCorps is inviting the public to come try electronic smart glasses designed to help those with severe visual impairments see better. The VisionCorps Foundation purchased one eSight and three NuEyes units to use for demonstrations and studying their impact on workers at the VisionCorps manufacturing, food processing and administrative businesses. Read more >>
Read more...

Aras $39.50 million Fundraising. Peter Schroer Released Sep 19 form

Aras Corp, Corporation just submitted form D for $39.50 million equity financing. This is a new filing. Aras was able to finance itself with $39.50 million. That is 100.00 % of the fundraising. The total private financing amount was $39.50 million. The financing document was filed on 2017-09-19. The reason for the financing was: unspecified. Read more >>
Read more...

Eyewear Industry Moving towards Building Smart Glasses Equipped with Sensors

For instance, eSight has developed the electronic glasses that can help people with limited vision who cannot see with ordinary glasses or lenses. The glasses developed by eSight transmits images from the camera to a small internal screen. These images are transferred in such a way that it beams the video into the person’s peripheral vision. Read more >>
Read more...

Corbus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 8:35 a.m. EDT in New York, NY. Read more >>
Read more...